Vitamin E has been suggested to modulate age-associated changes by altering the redox balance resulting in altered gene and/or protein expression. Here we have utilized proteomics to determine whether such regulation in protein expression occurs in human lymphocytes from two different age groups stressed with H₂O₂ and then treated with vitamin E in the form of tocotrienol-rich fraction (TRF). In this study, lymphocytes obtained from young (30-49 years old) and old (>50 years old) volunteers were first challenged with 1 mM H₂O₂. They were then treated by exposure to 50, 100 and 200 μg/ml TRF. Two-dimensional gel electrophoresis followed by MALDI-TOF/TOF (matrix-assisted laser desorption/ionization time-of-flight/time-of-flight) tandem mass spectrometry was then performed on whole-cell protein extracts to identify proteins that have changed in expression. A total of 24 proteins were found to be affected by H₂O₂ and/or TRF treatment. These included proteins that were related to metabolism, antioxidants, structural proteins, protein degradation and signal transduction. Of particular interest was the regulation of a number of proteins involved in stress response–peroxiredoxin-2, peroxiredoxin-3 and peroxiredoxin-6-all of which were shown to be down-regulated with H₂O₂ exposure. The effect was reversed following TRF treatment. The expression of peroxiredoxin-2 and peroxiredoxin-6 was confirmed by quantitative reverse transcriptase polymerase chain reaction. These results suggested that TRF directly influenced the expression dynamics of the peroxiredoxin-2, thus improving the cells ability to resist damage caused by oxidative stress.
Blog Archives
Vitamin E comprises a group of eight lipid soluble antioxidant compounds that are an essential part of the human diet. The α-isomers of both tocopherol and tocotrienol are generally considered to have the highest antioxidant activities. γ-tocopherol methyltransferase (γ-TMT) catalyzes the final step in vitamin E biosynthesis, the methylation of γ- and δ-isomers to α- and β-isomers. In present study, the Arabidopsis γ-TMT (AtTMT) cDNA was overexpressed constitutively or in the endosperm of the elite japonica rice cultivar Wuyujing 3 (WY3) by Agrobacterium-mediated transformation. HPLC analysis showed that, in brown rice of the wild type or transgenic controls with empty vector, the α-/γ-tocotrienol ratio was only 0.7, much lower than that for tocopherol (~19.0). In transgenic rice overexpressing AtTMT driven by the constitutive Ubi promoter, most of the γ-isomers were converted to α-isomers, especially the γ- and δ-tocotrienol levels were dramatically decreased. As a result, the α-tocotrienol content was greatly increased in the transgenic seeds. Similarly, over-expression of AtTMT in the endosperm also resulted in an increase in the α-tocotrienol content. The results showed that the α-/γ-tocopherol ratio also increased in the transgenic seeds, but there was no significant effect on α-tocopherol level, which may reflect the fact that γ-tocopherol is present in very small amounts in wild type rice seeds. AtTMT overexpression had no effect on the absolute total content of either tocopherols or tocotrienols. Taken together, these results are the first demonstration that the overexpression of a foreign γ-TMT significantly shift the tocotrienol synthesis in rice, which is one of the world’s most important food crops.
The aim of this work was to compare the intestinal absorption kinetics and bioavailability of γ-tocotrienol (γ-T3) and α-tocopherol (α-Tph) administered separately as oil solutions to rats invivo. Also, to explain the significant difference in both compounds oral bioavailability bycomparing their: 1) release profiles using the dynamic in-vitro lipolysis model, 2) intestinalpermeability, and 3) carrier-mediated uptake by Niemann-Pick C1-like 1 (NPC1L1) transporterwere examined. Absolute bioavailability studies were conducted after oral administration of γ-T3 or α-Tph prepared in corn oil to rats. In-situ rat intestinal perfusion with ezetimibe (NPC1L1 inhibitor) was performed to compare intestinal permeability. In-vitro interaction kinetics with NPC1L1 was examined in NPC1L1 transfected cells. While the in-vitro release studies demonstrated significantly higher release rate of γ-T3 in the aqueous phase, the oral bioavailability of α-Tph (36%) was significantly higher than γ-T3 (9%). Consequent in-situ studies revealed significantly higher intestinal permeability for α-Tph compared to γ-T3 in rats. Moreover, NPC1L1 kinetic studies demonstrated higher Vmax and Km values for α-Tph compared to γ-T3. Collectively, these results indicate that intestinal permeability is the main contributing factor for higher bioavailability of α-Tph. Also, these results emphasize the potentially important role of intestinal permeability in the bioavailability of γ-T3 suggesting that enhancing its permeability would increase its oral bioavailability.
Delta-tocotrienol augments cisplatin-induced suppression of non-small cell lung cancer cells via inhibition of the Notch-1 pathway
Ji, X., Wang, Z., Sarkar, F. H., Gupta, S. V.
Anticancer Res. 2012 Jul;32(7):2647-55.
Non-small cell lung cancer (NSCLC), accounting for 80% of lung cancers, is the leading cause of all cancer deaths. Previously, we demonstrated that delta-tocotrienol inhibits NSCLC cell proliferation, invasion and induces apoptosis by down-regulation of the Notch-1 signaling pathway. The objective of this study was to investigate whether delta-tocotrienol, could enhance the anticancer effects of cisplatin. Treatment with a combination of delta-tocotrienol and cisplatin resulted in a dose-dependent, significant inhibition of cell growth, migration, invasiveness, and induction of apoptosis in NSCLC cells, as compared to the single agents. This was associated with a decrease in NF-kappaB DNA binding activity, decrease in Notch-1, Hes-1, Bcl-2 and increase in cleaved Caspase-3 and PARP expressions. These results suggest that down-regulation of Notch-1, via inhibition of NF-kappaB signaling pathways by delta-tocotrienol and cisplatin, in combination, could provide a potential novel approach for tumor arrest in NSCLC, while lowering the effective dose of cisplatin.
Tocotrienol E: A Miracle of Mother Nature
Byron J. Richards
The only question a person might have after a thorough study oftocotrienol science would be, “Is there any health issue that tocotrienol E does not help?” The tocotrienol forms of vitamin E continue to be one of the most intensely researched nutrients in the world – with good reason. Seldom has there ever been any nutrient with such an impressive array of health benefits.
Tocotrienols in Rice Bran Oil Keep You Young
Vitamins are essential nutrients and therefore, they must come through the food we consume. Some vitamins are soluble in water while some are not. Vitamin E belongs to the class of fat soluble vitamins. The term “vitamin E” actually denotes two classes of compounds called tocopherols and tocotrienols. Both of them show vitamin E activity. There is a subtle difference in structure between the tocopherols and tocotrienols, the latter being more unsaturated. There are four each of tocopherols and tocotrienols. The best known function of vitamin E is to act as an antioxidant. The tocotrienols are in the news because of their superior antioxidant activity.
Woman’s World magazine includes Red Palm Fruit Oil in article on lowering breast cancer risk
Robin Miller
Everyone knows someone who has been affected by breast cancer. The deadly disease claims the lives of too many of our mothers, sisters and daughters each year. The good news is incidences of breast cancer have been dropping over the past decade, but we can’t stop there. News that products made with healthy palm oil may play a role in thwarting the spread of breast cancer cells is getting widespread attention.
A Double Blind Placebo Controlled Study On The Neuroprotective And Anti-Atherogenic Effects Of Palm Tocotrienol Rich Fraction (Palm Vitamin E)
Yuen Kah Hay, Phd
Ongoing
Objective: The purpose of the study is to assess the neuroprotective, anti atherogenic and hepatoprotective properties of tocotrienols (palm vitamin E) supplementation as determined by white matter lesion load on serial magnetic resonance imaging (MRI), carotid artery magnetic resonance angiography (MRA) and liver ultrasound (US) as well as lipid profile analysis.
Study Type: Interventional
Study Design: Phase 2, Randomized, Double –Blind
Subjects: Patients with cerebrovascular disorders
Intervention: Tocotrienol, placebo
Primary Outcome: Regression of white matter lesion load in terms of numbers and size in the brain [ Time Frame: 1 to 2 years ]
Secondary Outcome: 1) Regression of the carotid artery stenoses in terms of percentage [ Time Frame: 1 to 2 years ]
2) The improvement in the lipid profile other markers associated with increased cardiovascular risk [ Time Frame: 1 to 2 years ]
3) Improvement in liver echogenicity. [ Time Frame: 1 to 2 years ] [ Designated as safety issue: No ]
Tocotrienol E Boosts HDL Cholesterol While Lowering Advanced Glycation End Products
Byron J. Richards
The tocotrienol form of vitamin E is now on an anti-aging tear. Recently I reported how this form of vitamin E was shown to extend the length of telomeres, enabling cells to live longer. A new human study shows that it boosts protective HDL Cholesterol while lowering a key marker of aging – advanced glycation end products. A new animal experiment shows that tocotrienols significantly reduce the damage from experimentally induced stroke. These new studies add even more evidence of the extreme health benefits offered by this special form of vitamin E, as I extensively reviewed in my previous article, Tocotrienols: Twenty Years of Dazzling Cardiovascular and Cancer Research.
Gamma Tocotrienol Weakens and Kills Prostate Cancer Cells
Byron J. Richards
Protection of both women’s and men’s sexual organs is important for survival and quality of life. Previously, I reported on exciting research relating to gamma tocotrienol and breast cancer in my article, Gamma Tocotrienol for Breast Cancer Prevention and Treatment. New research now shows that gamma tocotrienol may be quite helpful for prostate cancer prevention and treatment.